HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Morehouse, L. A. Articles by Chandler, C. E. Search for Related Content PubMed PubMed Citation Articles by Morehouse, L. A. Articles by Chandler, C. E. Social Bookmarking                      What's this?

The Journal of Lipid Research, Vol. 40, 464-474, March 1999
Copyright © 1999 by Lipid Research, Inc.

Original Article

Comparison of synthetic saponin cholesterol absorption inhibitors in rabbits: evidence for a non-stoichiometric, intestinal mechanism of action

Correspondence to: Lee A. Morehouse

The hypocholesterolemic activities of pamaqueside and tiqueside, two structurally similar saponins, were evaluated in cholesterol-fed rabbits. The pharmacological profiles of the saponins were virtually identical: both dose-dependently decreased the intestinal absorption of labeled cholesterol 25–75%, increased fecal neutral sterol excretion up to 2.5-fold, and decreased hepatic cholesterol content 10–55%. High doses of pamaqueside (>5 mg/kg) or tiqueside (>125 mg/kg) completely prevented hypercholesterolemia. Decreases in plasma and hepatic cholesterol levels were strongly correlated with increased neutral sterol excretion. Ratios of neutral sterol excreted to pamaqueside administered were greater than 1:1 at all doses, in opposition to the formation of a stoichiometric complex previously suggested for tiqueside and other saponins. Ratios in tiqueside-treated rabbits were less than unity, a reflection of its lower potency. Pamaqueside-treated rabbits exhibited a more rapid decline in plasma cholesterol concentrations than control animals fed a cholesterol-free diet, indicating that the compound also inhibited the absorption of biliary cholesterol. Intravenous administration of pamaqueside had no effect on plasma cholesterol levels despite plasma levels twice those observed in rabbits given pamaqueside orally.

These data indicate that pamaqueside and tiqueside induce hypocholesterolemia by blocking lumenal cholesterol absorption via a mechanism that apparently differs from the stoichiometric complexation of cholesterol hypothesized for other saponins.—Morehouse, L. A., F-W. Bangerter, M. P. DeNinno, P. B. Inskeep, P. A. McCarthy, J. L. Pettini, Y. E. Savoy, E. D. Sugarman, R. W. Wilkins, T. C. Wilson, H. A. Woody, L. M. Zaccaro, and C. E. Chandler. Comparison of synthetic saponin cholesterol absorption inhibitors in rabbits: evidence for a non-stoichiometric, intestinal mechanism of action. J. Lipid Res. 1999. 40: 464 – 474.

Supplementary key words: tiqueside, pamaqueside, hypocholesterolemic, fecal neutral sterols

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S.-O. Lee, A. L. Simons, P. A. Murphy, and S. Hendrich Soyasaponins Lowered Plasma Cholesterol and Increased Fecal Bile Acids in Female Golden Syrian Hamsters Experimental Biology and Medicine, July 1, 2005; 230(7): 472 - 478. [Abstract] [Full Text] [PDF]

				E. Levy, D. Menard, I. Suc, E. Delvin, V. Marcil, L. Brissette, L. Thibault, and M. Bendayan Ontogeny, immunolocalisation, distribution and function of SR-BI in the human intestine J. Cell Sci., January 15, 2004; 117(2): 327 - 337. [Abstract] [Full Text] [PDF]

				M. V.T. Lobo, L. Huerta, N. Ruiz-Velasco, E. Teixeiro, P. de la Cueva, A. Celdran, A. Martin-Hidalgo, M. A. Vega, and R. Bragado Localization of the Lipid Receptors CD36 and CLA-1/SR-BI in the Human Gastrointestinal Tract: Towards the Identification of Receptors Mediating the Intestinal Absorption of Dietary Lipids J. Histochem. Cytochem., October 1, 2001; 49(10): 1253 - 1260. [Abstract] [Full Text] [PDF]

				N. N. Izzat, M. E. Deshazer, and D. S. Loose-Mitchell New Molecular Targets for Cholesterol-Lowering Therapy J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 315 - 320. [Abstract] [Full Text]